Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | PARG | Q86W56 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26291939 | 0.91 | TDP1 (0.42) | DRD2TDP1CA12CA1CA2 | |
| SCHEMBL20139538 | 0.82 | DRD2 (0.40) | GAADRD2TDP1ALDH1A1GFER | |
| SCHEMBL25407942 | 0.82 | GAA (0.46) | GAASMN1; SMN2CA12CA1CA2 | |
| SCHEMBL20401167 | 0.81 | DRD2 (0.39) | GAADRD2TDP1ALDH1A1GFER | |
| SCHEMBL1890830 | 0.80 | ALDH1A1 (0.37) | GAADRD2TDP1SMN1; SMN2CA12 | |
| SCHEMBL29853762 | 0.79 | SCN9A (0.46) | GAADRD2SMN1; SMN2ALDH1A1BRD4 | |
| SCHEMBL12725198 | 0.79 | TDP1 (0.44) | GAATDP1SMN1; SMN2PKM | |
| SCHEMBL31319578 | 0.79 | TDP1 (0.44) | GAATDP1SMN1; SMN2PKM | |
| SCHEMBL12800195 | 0.78 | TDP1 (0.46) | GAATDP1SMN1; SMN2ALDH1A1PKM | |
| SCHEMBL29544423 | 0.78 | TDP1 (0.44) | GAATDP1SMN1; SMN2PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022072634-A1 | BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER | SCORPION THERAPEUTICS, INC. (US) | 2022-04-07 | — | — | WO | disclosed |